I‐Zu Huang

967 total citations
8 papers, 649 citations indexed

About

I‐Zu Huang is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, I‐Zu Huang has authored 8 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in I‐Zu Huang's work include Potassium and Related Disorders (4 papers), Heart Failure Treatment and Management (3 papers) and Pain Management and Opioid Use (2 papers). I‐Zu Huang is often cited by papers focused on Potassium and Related Disorders (4 papers), Heart Failure Treatment and Management (3 papers) and Pain Management and Opioid Use (2 papers). I‐Zu Huang collaborates with scholars based in United States, Germany and France. I‐Zu Huang's co-authors include Bertram Pitt, N.A. Gratsiansky, Peter H. Stone, Lixin Meng, David A. Bushinsky, Faı̈ez Zannad, Dalane W. Kitzman, Stefan D. Anker, Jerry Buysse and Michael Saulino and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Pain Medicine.

In The Last Decade

I‐Zu Huang

7 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I‐Zu Huang United States	5	425	306	158	129	69	8	649
Abdul Al‐Hesayen Canada	16	637 1.5×	135 0.4×	34 0.2×	81 0.6×	139 2.0×	31	930
I. Milocco Sweden	13	377 0.9×	113 0.4×	52 0.3×	68 0.5×	45 0.7×	38	671
C V Leier United States	11	681 1.6×	137 0.4×	67 0.4×	47 0.4×	88 1.3×	15	847
Sally S. Cutler United States	15	641 1.5×	200 0.7×	33 0.2×	149 1.2×	61 0.9×	21	803
Patricia Huss United States	9	636 1.5×	147 0.5×	79 0.5×	42 0.3×	66 1.0×	13	816
Timothy S. Callahan United States	11	535 1.3×	82 0.3×	26 0.2×	90 0.7×	35 0.5×	19	693
James R. Foster United States	17	554 1.3×	64 0.2×	21 0.1×	50 0.4×	97 1.4×	50	873
M Safar France	13	631 1.5×	176 0.6×	47 0.3×	61 0.5×	29 0.4×	44	813
A. Bénétos France	9	718 1.7×	201 0.7×	55 0.3×	84 0.7×	20 0.3×	32	849
Edward D. Gilmore Canada	9	227 0.5×	28 0.1×	29 0.2×	153 1.2×	74 1.1×	12	577

Countries citing papers authored by I‐Zu Huang

Since Specialization

Citations

This map shows the geographic impact of I‐Zu Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Zu Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Zu Huang more than expected).

Fields of papers citing papers by I‐Zu Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Zu Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Zu Huang. The network helps show where I‐Zu Huang may publish in the future.

Co-authorship network of co-authors of I‐Zu Huang

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Zu Huang. A scholar is included among the top collaborators of I‐Zu Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Zu Huang. I‐Zu Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

McDowell, Gladstone, Michael Saulino, Mark S. Wallace, et al.. (2020). Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM). Pain Medicine. 21(11). 2925–2938. 6 indexed citations

Saulino, Michael, Gladstone McDowell, Richard Rauck, et al.. (2017). Poster 110: Effectiveness and Safety of Intrathecal Ziconotide Use as the First Agent in Pump. PM&R. 9(9S1).

Deer, Timothy R., Richard Rauck, Philip Kim, et al.. (2017). Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM). Pain Practice. 18(2). 230–238. 27 indexed citations

Pitt, Bertram, Stefan D. Anker, David A. Bushinsky, et al.. (2011). Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. European Heart Journal. 32(7). 820–828. 305 indexed citations

Pitt, Bertram, David A. Bushinsky, Mitja Lainščak, et al.. (2011). A MULTICENTER STUDY OF DOSE TITRATION OF THE ORAL POTASSIUM BINDER RLY5016 TO MAINTAIN NORMAL SERUM POTASSIUM IN PATIENTS WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE TREATED WITH RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS AND/OR ?-BLOCKERS. Journal of the American College of Cardiology. 57(14). E301–E301. 3 indexed citations

Buysse, Jerry, I‐Zu Huang, & Bertram Pitt. (2011). PEARL-HF: Prevention of Hyperkalemia in Patients With Heart Failure Using a Novel Polymeric Potassium binder, RLY5016. Future Cardiology. 8(1). 17–28. 52 indexed citations

Pitt, Bertram, I‐Zu Huang, Stefan D. Anker, et al.. (2010). The PEARL-HF (Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose to Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial. Journal of Cardiac Failure. 16(11). 912–912. 3 indexed citations

Stone, Peter H., et al.. (2006). Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine. Journal of the American College of Cardiology. 48(3). 566–575. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact